ArticlePDF Available

Association between the Number of Eggs and Live Birth in IVF Treatment: An Analysis of 400 135 Treatment Cycles

Authors:

Abstract and Figures

While live birth is the principal clinical outcome following in vitro fertilization (IVF) treatment, the number of eggs retrieved following ovarian stimulation is often used as a surrogate outcome in clinical practice and research. The aim of this study was to explore the association between egg number and live birth following IVF treatment and identify the number of eggs that would optimize the IVF outcome. Anonymized data on all IVF cycles performed in the UK from April 1991 to June 2008 were obtained from the Human Fertilization and Embryology Authority (HFEA). We analysed data from 400 135 IVF cycles. A logistic model was fitted to predict live birth using fractional polynomials to handle the number of eggs as a continuous independent variable. The prediction model, which was validated on a separate HFEA data set, allowed the estimation of the probability of live birth for a given number of eggs, stratified by age group. We produced a nomogram to predict the live birth rate (LBR) following IVF based on the number of eggs and the age of the female. The median number of eggs retrieved per cycle was 9 [inter-quartile range (IQR) 6-13]. The overall LBR was 21.3% per fresh IVF cycle. There was a strong association between the number of eggs and LBR; LBR rose with an increasing number of eggs up to ∼15, plateaued between 15 and 20 eggs and steadily declined beyond 20 eggs. During 2006-2007, the predicted LBR for women with 15 eggs retrieved in age groups 18-34, 35-37, 38-39 and 40 years and over was 40, 36, 27 and 16%, respectively. There was a steady increase in the LBR per egg retrieved over time since 1991. The relationship between the number of eggs and live birth, across all female age groups, suggests that the number of eggs in IVF is a robust surrogate outcome for clinical success. The results showed a non-linear relationship between the number of eggs and LBR following IVF treatment. The number of eggs to maximize the LBR is ∼15.
Content may be subject to copyright.
ORIGINAL ARTICLE Infertility
Association between the number of
eggs and live birth in IVF treatment:
an analysis of 400 135 treatment cycles
Sesh Kamal Sunkara1, Vivian Rittenberg1, Nick Raine-Fenning2,
Siladitya Bhattacharya3, Javier Zamora4, and Arri Coomarasamy5,*
1
Assisted Conception Unit, Guy’s and St Thomas’ Foundation Trust, King’s College London, London, UK
2
Nottingham University Research
and Treatment Unit in Reproduction (NURTURE), Division of Human Development, School of Clinical Sciences, University of Nottingham,
Nottingham, UK
3
Division of Applied Health Sciences, School of Medicine and Dentistry, University of Aberdeen, Aberdeen, UK
4
Clinical
Biostatistics Unit, Hospital Ramon y Cajal. IRYCIS. CIBERESP, University Complutense of Madrid, Spain
5
School of Clinical and Experimental
Medicine, College of Medical & Dental Sciences, University of Birmingham, Academic Unit, 3rd Floor, Birmingham Women’s Hospital,
Birmingham B15 2TG, UK
*Correspondence address. Tel: +44-121-623-6835; Fax: +44-121-626-6619; E-mail: a.coomarasamy@bham.ac.uk
Submitted on December 10, 2010; resubmitted on March 2, 2011; accepted on March 10, 2011
background: While live birth is the principal clinical outcome following in vitro fertilization (IVF) treatment, the number of eggs
retrieved following ovarian stimulation is often used as a surrogate outcome in clinical practice and research. The aim of this study was
to explore the association between egg number and live birth following IVF treatment and identify the number of eggs that would optimize
the IVF outcome.
methods: Anonymized data on all IVF cycles performed in the UK from April 1991 to June 2008 were obtained from the Human Ferti-
lization and Embryology Authority (HFEA). We analysed data from 400 135 IVF cycles. A logistic model was fitted to predict live birth using
fractional polynomials to handle the number of eggs as a continuous independent variable. The prediction model, which was validated on a
separate HFEA data set, allowed the estimation of the probability of live birth for a given number of eggs, stratified by age group. We pro-
duced a nomogram to predict the live birth rate (LBR) following IVF based on the number of eggs and the age of the female.
results: The median number of eggs retrieved per cycle was 9 [inter-quartile range (IQR) 6– 13]. The overall LBR was 21.3% per fresh
IVF cycle. There was a strong association between the number of eggs and LBR; LBR rose with an increasing number of eggs up to !15,
plateaued between 15 and 20 eggs and steadily declined beyond 20 eggs. During 20062007, the predicted LBR for women with 15 eggs
retrieved in age groups 18– 34, 35 37, 38 39 and 40 years and over was 40, 36, 27 and 16%, respectively. There was a steady increase in
the LBR per egg retrieved over time since 1991.
conclusion: The relationship between the number of eggs and live birth, across all female age groups, suggests that the number of eggs
in IVF is a robust surrogate outcome for clinical success. The results showed a non-linear relationship between the number of eggs and LBR
following IVF treatment. The number of eggs to maximize the LBR is !15.
Key words: IVF treatment / egg numbers / live birth / nomogram
Introduction
The primary aim of in vitro fertilization (IVF) treatment is to achieve a
term live birth. However, as the number of eggs retrieved is con-
sidered to be an important prognostic variable, IVF treatment proto-
cols aim to optimize this outcome. Studies evaluating IVF treatment
regimens and ovarian reserve tests such as anti-mu
¨llerian hormone
or antral follicle count often use the number of eggs as a surrogate
outcome. However, this practice has been criticized (Vail and Gar-
dener, 2003) as the relationship between the number of eggs and
live birth is poorly understood.
Previous work on the relationship between the number of eggs
retrieved and pregnancy rates following IVF, based on data from
single centres and involving small sample sizes, has shown conflicting
results (Meniru and Craft 1997;Letterie et al., 2005;Kably Ambe
et al., 2008;Molina Hita Ma. del et al., 2008;Hamoda et al.,
2010). None has reported live birth rates (LBRs), but instead
focused on rates of clinical or ongoing pregnancy. The aim of our
study was to determine the association between the number of
eggs retrieved and the LBR in fresh IVF cycles, based on the
analysis of a large national database involving 400 135 IVF treatment
cycles.
&The Author 2011. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved.
For Permissions, please email: journals.permissions@oup.com
Human Reproduction, Vol.0, No.0 pp. 1– 7, 2011
doi:10.1093/humrep/der106
Hum. Reprod. Advance Access published May 10, 2011
at McGill University Libraries on May 10, 2011humrep.oxfordjournals.orgDownloaded from
Materials and Methods
Anonymized data were obtained from the Human Fertilization and Embry-
ology Authority (HFEA) for all IVF cycles performed in the UK from April
1991 to June 2008 (www.hfea.gov.uk/5874.html, HFEA authority). The
HFEA, which is the statutory regulator of assisted conception treatment
in the UK, has collected data on all IVF treatment cycles performed in
the UK since its inception in 1991. Overall, 787 030 IVF cycles were
recorded in this period. For the purpose of the study, cycles involving
gamete or zygote intra-fallopian transfer (GIFT, ZIFT), egg donation, egg
sharing, embryo donation or where the source of embryos was not
specified, preimplantation genetic diagnosis, surrogacy, oocyte cryopreser-
vation, frozen embryo replacement, and cycles where no eggs were
retrieved or all embryos were frozen were excluded from the analysis.
Information was obtained on the number of eggs retrieved, age group
(1834, 35–37, 38 39, 40 years and over), treatment period (1991
2008) and live birth outcome. A live birth is defined as any birth event
in which at least one baby is born alive.
Statistical analysis
We described the characteristics of the cohort using absolute and relative
frequencies for categorical variables, and means and medians with
measures of spread for continuous variables. We computed crude LBRs
for the whole cohort, and stratified by period of treatment and age.
To explore the association between the number of eggs and live birth
outcome, we fitted a maximum likelihood logistic model with live birth
outcome as the dependent variable and using a fractional polynomial to
handle the number of eggs as a continuous independent variable. We
used the closed test procedure for function selection as described by
Royston and Sauerbrei (2008). We also introduced in the model indicator
variables for age and period of treatment. We computed robust standard
errors to account for the non-independence of observations from multiple
treatment cycles in a single participant.
The model calibration and discrimination ability was assessed by the
HosmerLemeshow test and the c-index statistic. The live birth
outcome has substantially improved over the four time periods and
thus, for the development of the prediction model, we used the data
set generated after 2006. As the age of the woman has a significant
impact in determining the probability of a live birth, we computed this
probability stratified by age group.
To validate our model, we split the cohort into two parts according to
the period of treatment. The first, comprising cycles performed between
2006 and 2007, was used to derive the model, while data generated from
2008 onwards were used to validate it. Finally, we constructed a nomo-
gram to calculate the probability of a live birth based on the number of
eggs and age.
Figure 1 Data selection process.
2Sunkara et al.
at McGill University Libraries on May 10, 2011humrep.oxfordjournals.orgDownloaded from
Results
The data selection process with the numbers of cycles excluded (with
reasons for exclusion) is provided in Fig. 1. Of an initial total of
787 030 cycles, 400 135 were eligible for analysis. Characteristics of
the analysis cohort are given in Table I. Half of all cycles were con-
ducted on women between 18 and 34 years of age, while 12.6%
were in women 40 years or over. The major cause of infertility was
male factor (56.3%), and conventional IVF was used in the majority
(61.9%) of cycles.
The median number of eggs retrieved was 9 [inter-quartile range
(IQR) 613; Fig. 2a] and the median number of embryos created
was 5 (IQR 38; Fig. 2b). The overall LBR in the entire cohort was
21.3% [95% confidence interval (CI): 21.221.4%], with a gradual
rise over the four time periods in this study (14.9% in 1991– 1995,
19.8% in 19962000, 23.2% in 20012005 and 25.6% in
20062008).
Association between the number of eggs
and live birth
There was a strong association between the number of eggs and the
LBR (Fig. 3a) which rose with increasing number of eggs up to !15,
plateaued between 15 and 20 eggs and steadily declined beyond 20
eggs. The same pattern was observed in all four of the time
periods. For a given number of eggs, LBRs increased over time
(Fig. 3b) but decreased with increasing age (Fig. 3c).
Predicting live birth
To ensure that the predicted LBR was relevant to current practice, the
predictive model was derived from observations generated from data
on treatments from 2006 to 2007. The data from 2008 were used for
model validation. The final model, which includes non-linear terms for
the number of eggs and age as an indicator variables, closely fits with
observed data (Fig. 4). The functional form of the model with coeffi-
cients and their robust standard errors is provided in Appendix
(Supplementary data). The model was well calibrated (Hosmer–
Lemeshow
x
2
¼3.92, df ¼8, P¼0.86) and the c-index was 0.65.
........................................................................................
Table I Characteristics of the cohort (n5400 135).
Characteristic n(%)
Age (given categories)
18–34 years 200 982 (50.2)
35–37 years 97 345 (24.3)
38–39 years 51 385 (12.8)
40 years and over 50 423 (12.6)
Number of previous IVF cycles
0 230 924 (58.8)
1 87 471 (22.3)
2 40 994 (10.4)
3 or more 33 157 (8.5)
Previous LB (yes) 18 633 (4.7)
Cause of infertility
a
Male factor 221 047 (56.3)
Tubal disease 117 722 (30.3)
Ovulatory disorder 46 071 (11.9)
Endometriosis 29 804 (7.5)
Unexplained 131 652 (33.7)
Treatment type
IVF 247 640 (61.9)
ICSI 151 788 (37.9)
Unknown 707 (0.2)
Eggs retrieved (Fig. 2a)
Median (IQR) 9 (6–13)
Embryos created (Fig. 2b)
Median (IQR) 5 (3–8)
Treatment cycles in each period
1991– 1995 72 682 (18.2)
1996– 2000 117 050 (29.3)
2001– 2005 129 402 (32.3)
2006 onwards 81 001 (20.2)
a
The causes of infertility are not mutually exclusive.
Figure 2 Number of eggs retrieved and embryos created.
Number of eggs and live birth in IVF treatment 3
at McGill University Libraries on May 10, 2011humrep.oxfordjournals.orgDownloaded from
The predicted probability of live birth for a given number of eggs
and age group is provided in Table II. This information is summarized
in the nomogram (Fig. 5), which provides a graphic depiction for easy
interpretation of the results.
Validation was performed on 17 366 IVF cycles and 4863 live births.
Predictive ability of the model does not differ between the derivation
and validation cohorts. Although the HosmerLemeshow
x
2
¼16.3
(df ¼8, P¼0.04) is statistically significant due to the large sample
size, the differences between predicted and observed live birth prob-
abilities are clinically unimportant (Fig. 6). The c-index was 0.66 for the
temporal validation cohort.
Discussion
Our results show a strong relationship between the number of eggs
and the LBR in a fresh IVF cycle. The best chance of live birth was
associated with the number of eggs of around 15 and showed a
decline with .20 eggs. LBRs were seen to decline with advancing
maternal age although a global increase over time was noted across
all age groups.
We used the largest available clinical IVF database to assess the
association between the number of eggs and live birth in a fresh IVF
cycle. Although the clinical heterogeneity within the data set may be
considered a drawback, such differences increase the generalizability
of our findings. The model has been derived using more recent data
(20062007) which closely represent current practice and validated
using the most recent subset of IVF cycles within the cohort (2008)
constituting a temporal external validation as current recommen-
dations advocate.
Although the size of the database was large, we encountered pro-
blems with missing data and loss to follow-up; such data were
excluded from the analysis. Data involving cycles where all embryos
were frozen for reasons such as risk of ovarian hyperstimulation
Figure 3 Association between egg number and live birth rate.
Figure 4 Observed versus predicted live birth rate in data from
2006 to 2007.
4Sunkara et al.
at McGill University Libraries on May 10, 2011humrep.oxfordjournals.orgDownloaded from
......................................................... ........................................................... .......................................................... ..........................................................
..........................................................................................................................................................................................................................................................
Table II Predicted probabilities for live birth.
18–34 years 35– 37 years 38–39 years 40 years and over
Eggs nObserved
live birth
(%)
Predicted
live birth
(%)
95%CI
predicted
(%)
nObserved
live birth
(%)
Predicted
live birth
(%)
95%CI
predicted
(%)
nObserved
live birth
(%)
Predicted
live birth
(%)
95%CI
predicted
(%)
nObserved
live birth
(%)
Predicted
live birth
(%)
95%CI
predicted
(%)
1 253 8 7 7, 8 275 7 6 6, 7 280 5 4 4, 5 541 1 2 2, 3
2 540 17 16 15, 17 579 14 14 13, 14 509 9 9 9, 10 774 5 5 5, 5
3 819 21 22 21, 22 840 18 19 18, 19 718 12 13 13, 14 1002 6 7 7, 8
4 1221 29 26 25, 26 1091 22 22 22, 23 817 17 16 15, 17 1025 9 9 8, 9
5 1486 29 29 28, 29 1245 24 25 24, 26 899 18 18 17, 19 1058 11 10 10, 11
6 1684 30 31 30, 31 1298 27 27 26, 28 854 18 20 19, 21 980 9 11 11, 12
7 1809 35 33 32, 33 1321 29 29 28, 30 846 21 21 20, 22 901 11 12 11, 13
8 1904 34 34 34, 35 1278 29 30 30, 31 729 23 22 22, 23 771 11 13 12, 14
9 1898 35 36 35, 36 1207 31 31 31, 32 672 23 23 23, 24 627 15 14 13, 14
10 1805 36 37 36, 37 1168 31 33 32, 33 630 25 24 23, 25 538 14 14 13, 15
11 1795 36 38 37, 38 1035 34 33 33, 34 549 23 25 24, 26 466 17 15 14, 15
12 1639 38 38 38, 39 872 34 34 33, 35 474 26 26 25, 27 401 15 15 14, 16
13 1484 38 39 38, 40 703 34 35 34, 36 411 26 26 25, 27 298 16 15 15, 16
14 1291 40 40 39, 40 675 37 35 34, 36 329 26 27 26, 28 252 16 16 15, 17
15 1155 40 40 39, 41 526 41 36 35, 37 256 26 27 26, 28 229 17 16 15, 17
20 487 41 41 41, 42 219 36 37 36, 38 93 29 28 27, 29 74 18 17 16, 18
25 172 42 41 40, 43 63 43 37 36, 38 37 30 28 27, 30 19 26 17 16, 18
30 67 31 40 38, 42 20 50 36 33, 38 4 0 27 25, 29 12 25 16 14, 18
35 14 29 37 33, 41 7 29 33 29, 37 5 0 25 22, 28 0 15 13, 17
40 15 27 33 28, 40 7 43 30 24, 35 2 50 22 18, 27 0 13 11, 16
Number of eggs and live birth in IVF treatment 5
at McGill University Libraries on May 10, 2011humrep.oxfordjournals.orgDownloaded from
syndrome (OHSS) also could not be analysed. Also, our study only
analysed the outcome of fresh IVF cycles, and did not take into
account the impact of frozen– thawed cycles on the cumulative LBR
(due to data currently not being available as the current HFEA data
set does not allow linkage of fresh and frozen cycles in the same
woman). It is possible that the declining effect of higher number of
eggs on the outcome of a fresh IVF cycle becomes attenuated by
the increasing likelihood of a pregnancy in a subsequent frozen
thawed transfer cycle. The existing format of the anonymized data
set precluded detailed exploration of age-related outcomes other
than comparison of the existing age categories. This has certain
drawbacks; for example, over half of all women were in the same
age group (1834 years). At the other end of the spectrum, all
women over 40 years were treated as a homogeneous group although
outcomes in older women change significantly with small increases in
age, with LBRs of 11.9% in women aged 4042 years falling to 3.4% in
women aged 43 44 years (http://www.hfea.gov.uk/ivf-figures, HFEA
authority). No information regarding type of stimulation or gonado-
trophins used in IVF treatment was collected by the HFEA, and
these data were therefore unavailable for analysis.
Previous studies looking at the relationship between the number of
eggs and pregnancy rates have reported inconsistent results in showing
that pregnancy rates increased with an increasing number of eggs
(Meniru and Craft, 1997), best pregnancy rates being obtained with
number of eggs of 1015 (Kably Ambe et al., 2008), or 716
(Molina Hita Ma. del M et al., 2008). Furthermore, these studies
involved small numbers and were reported from single centres,
which limited their generalizability. Our study is the first to provide
vital information on predicting the LBR on the basis of eggs retrieved
in women of different age groups. The simplicity of the nomogram
facilitates interpretation of this information by clinicians as well as
couples seeking IVF treatment.
Knowledge of factors predicting IVF success is critical to patients and
service providers in informing decisions to embark on IVF treatment and
the choice of ovarian stimulation regimens. Such information is also
helpful in counselling couples about deciding against further IVF treat-
ment or plans to opt for donor eggs. To date, most clinical decisions
on ovarian stimulation in IVF have been based on ovarian reserve
tests which are good at predicting numbers of eggs retrieved but poor
in terms of predicting live birth (Broekmans et al., 2006;Broer et al.,
2009). By allowing clinicians to link the (predicted) number of eggs to
live birth, the nomogram generated by this study is likely to facilitate
use of these tests to optimize outcomes in IVF while preventing compli-
cations relating to production of an excessive number of eggs.
Figure 5 Nomogram to calculate predicted live birth probability given egg number and age.
Figure 6 Calibration plot of the validation model. Circles indicate
the observed proportion of live births per tenth of predicted prob-
ability. The dashed line represents perfect calibration.
6Sunkara et al.
at McGill University Libraries on May 10, 2011humrep.oxfordjournals.orgDownloaded from
Our data suggest that around 15 eggs may be the optimal number
to aim for in a fresh IVF cycle in order to maximize treatment
success while minimizing the risk of OHSS which is associated with
high number of eggs of .18 (Lyons et al., 1994;Verwoerd et al.,
2008;Lee et al., 2010). The decline in the LBR observed with
higher number of eggs could be due to the deleterious effect of
the raised serum estradiol levels affecting embryo implantation (Val-
buena et al., 2001;Mitwally et al., 2006;Joo et al., 2010). Even in
cases where the aim is to freeze surplus embryos for future use,
existing data suggest that the numbers of embryos frozen after a
fresh IVF cycle are not enhanced by retrieving .18 eggs (Hamoda
et al., 2010). On the other hand, there has been a recent trend
towards mild ovarian stimulation in IVF with the emphasis on reco-
vering fewer eggs than previously deemed optimal (Fauser et al.,
2010). Our findings support the use of moderate stimulation proto-
cols over either mild or aggressive stimulation protocols in IVF
treatment.
The nomogram that we have established is the first of its kind that
allows prediction of live birth for a given number of eggs and female
age group. This is potentially valuable for patients and clinicians in plan-
ning IVF treatment protocols and counselling regarding the prognosis
for a live birth occurrence, especially in women with either predicted
or a previous poor ovarian response.
The relationship observed between the number of retrieved eggs
and live birth in a fresh IVF cycle, across all female age groups,
suggests that number of eggs is a reasonable surrogate outcome
to use in IVF practice and research. Future research should focus
on establishing the relationship between retrieved eggs and the
cumulative LBR per IVF cycle by including the outcome following
replacement of all frozen embryos generated from a single fresh
IVF treatment.
Authors’ roles
S.K.S. undertook the task of verifying and validating the HFEA data
and contributed to writing the manuscript. V.R. undertook the task
of verifying and validating the HFEA data. N.R.-F. contributed to
writing the manuscript. S.B. contributed to writing the manuscript
and appraised it critically for important intellectual content. J.Z.
undertook the analysis of the data and contributed to writing the
manuscript. A.C. conceived the idea and contributed to writing
the manuscript.
Supplementary data
Supplementary data are available at http://humrep.oxfordjournals.
org/.
Acknowledgements
We thank all the centres in the UK for their work in completing and
forwarding all the treatment and outcome details to the HFEA, and
the staff at the HFEA for validating this data.
Conflict of interest: none declared.
References
Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic
review of tests predicting ovarian reserve and IVF outcome. Hum
Reprod Update 2006;12:685718.
Broer SL, Mol BW, Hendriks D, Broekmans FJ. The role of antimullerian
hormone in prediction of outcome after IVF: comparison with the
antral follicle count. Fertil Steril 2009;91:705714.
Fauser BC, Nargund G, Andersen AN, Norman R, Tarlatzis B, Boivin J,
Ledger W. Mild ovarian stimulation for IVF: 10 years later. Hum
Reprod 2010;25:2678– 2684.
Hamoda H, Sunkara S, Khalaf Y, Braude P, El-Toukhy T. Outcome of fresh
IVF/ICSI cycles in relation to the number of oocytes collected: a review
of 4,701 treatment cycles. Hum Reprod 2010;25:147.
HFEA authority. Access Anonymised HFEA Data. (19 November 2010, date
last acccesed) http://www.hfea.gov.uk/5874.html.
HFEA authority. http://www.hfea.gov.uk/ivf-figures-2006.html. (19
November 2010, date last acccesed).
Joo BS, Park SH, An BM, Kim KS, Moon SE, Moon HS. Serum oestradiol
levels during controlled ovarian hyperstimulation influence the
pregnancy outcome of in vitro fertilization in a concentration-
dependent manner. Fertil Steril 2010;93:442 446.
Kably Ambe A, Estevez Gonzalez S, Carballo Mondragon E, Dura
´n
Monterrosas L. Comparative analysis of pregnancy rate/captured
oocytes in an in vitro fertilization program. Ginecol Obstet Mex 2008;
76:256260. Spanish
Lee KH, Kim SH, Jee BC, Kim YJ, Suh CS, Kim KC, Lee WD. Comparison
of clinical characteristics between early and late patterns in hospitalized
patients with ovarian hyperstimulation syndrome. Fertil Steril 2010;
93:22742280.
Letterie G, Marshall L, Angle M. The relationship of clinical response,
oocyte number, and success in oocyte donor cycles. J Assist Reprod
Genet 2005;22:115117.
Lyons CA, Wheeler CA, Frishman GN, Hackett RJ, Seifer DB, Haning RV
Jr. Early and late presentation of the ovarian hyperstimulation syndrome:
two distinct entities with different risk factors. Hum Reprod 1994;
9:792799.
Meniru GI, Craft IL. Utilization of retrieved oocytes as an index of the
efficiency of superovulation strategies for in-vitro fertilization
treatment. Hum Reprod 1997;12:2129– 2132.
Mitwally MF, Bhakoo HS, Crickard K, Sullivan MW, Batt RE, Yeh J.
Estradiol production during controlled ovarian hyperstimulation
correlates with treatment outcome in women undergoing in vitro
fertilization-embryo transfer. Fertil Steril 2006;86:588596.
Molina Hita Ma. del M, Lobo Martinez S, Gonzalez Varea, Montejo
Gadea JM, Garijo Lopez E, Cuadrado Mangas C. Correlation between
the number of oocytes and the pregnancy rate in IVF-ICSI cycles.
Revista Iberoamericana de Fertilidad y Reproduccion Humana 2008;
25:153159. Spanish
Royston P, Sauerbrei W. Multivariate Model-Building: a Pragmatic Approach
to Regression Analysis Based on Fractional Polynomials for Modelling
Continuous Variables. Chichester, West Sussex, England: John Wiley &
Sons, 2008.
Vail A, Gardener E. Common statistical errors in the design and analysis of
subfertility trials. Hum Reprod 2003;18:1000–1004.
Valbuena D, Martin J, de Pablo JL, Remohı
´J, Pellicer A, Simo
´nC.
Increasing levels of estradiol are deleterious to embryonic
implantation because they directly affect the embryo. Fertil Steril
2001;76:962968.
Verwoerd GR, Mathews T, Brinsden PR. Optimal follicle and oocyte
numbers for cryopreservation of all embryos in IVF cycles at risk of
OHSS. Reprod Biomed Online 2008;17:312– 317.
Number of eggs and live birth in IVF treatment 7
at McGill University Libraries on May 10, 2011humrep.oxfordjournals.orgDownloaded from
... A poor response to stimulation may result in IVF cycle cancellation with no attempt to retrieve oocytes. However, the simple assumption that high doses of gonadotropins lead to better stimulation outcomes is misleading, as this increases the risk of ovarian hyperstimulation syndrome (OHSS) [4,[6][7][8][9]. Administration of gonadotropins at the lowest effective dose is, therefore, essential to achieve the desired result of stimulation while minimizing the side effects for the patient as well as the cost of treatment, recognizing the significant impact of medical expenses. ...
... We found that increasing the dose of gonadotropins administered on days 1-3 did not significantly affect the MII ratio in patients with low (1-3) and intermediate (4)(5)(6)(7)(8) oocyte predictions (Fig. 2). However, in the group predicted to produce 9-12 oocytes, the MII ratio significantly increased in patients receiving 225 and 300 IU/ ...
... We observed that increasing the gonadotropin dose administered during this period did not significantly change the MII ratio in patients with low (1-3) and intermediate (4)(5)(6)(7)(8) oocyte predictions (Fig. 3). Only patients predicted to have 9-12 oocytes responded significantly better to 225 IU/day than to 150 IU/day gonadotropins. ...
Article
Full-text available
Purpose Ovarian stimulation with gonadotropins is crucial for obtaining mature oocytes for in vitro fertilization (IVF). Determining the optimal gonadotropin dosage is essential for maximizing its effectiveness. Our study aimed to develop a machine learning (ML) model to predict oocyte counts in IVF patients and retrospectively analyze whether higher gonadotropin doses improve ovarian stimulation outcomes. Methods We analyzed the data from 9598 ovarian stimulations. An ML model was employed to predict the number of mature metaphase II (MII) oocytes based on clinical parameters. These predictions were compared with the actual counts of retrieved MII oocytes at different gonadotropin dosages. Results The ML model provided precise predictions of MII counts, with the AMH and AFC being the most important, and the previous stimulation outcome and age, the less important features for the prediction. Our findings revealed that increasing gonadotropin dosage did not result in a higher number of retrieved MII oocytes. Specifically, for patients predicted to produce 4–8 MII oocytes, a decline in oocyte count was observed as gonadotropin dosage increased. Patients with low (1–3) and high (9–12) MII predictions achieved the best results when administered a daily dose of 225 IU; lower and higher doses proved to be less effective. Conclusions Our study suggests that high gonadotropin doses do not enhance MII oocyte retrieval. Our ML model can offer clinicians a novel tool for the precise prediction of MII to guide gonadotropin dosing.
... Assessment of ovarian reserve markers helps the clinician with tailored and individualised ovarian stimulation protocol for infertile women undergoing in vitro-fertilisation (IVF) procedures [1]. Parameters like chronological age, ovarian reserve markers (baseline serum follicle stimulating hormone (FSH) and anti-mullerian hormone (AMH), BMI, ovarian response in previous stimulation cycles, or combination of these factors are used for starting gonadotrophin dose calculation for each woman. ...
... Noteworthy, if one combines the two studies (6 successes out of 96 + 54 treated subjects), the rate of success would be 4.0% (95% CI 1.5-8.5%). Some limitations must be acknowledged for the present study: the limited simple size for the rescue IUI group, the low pregnancy rates in both groups, and the inclusion of patients submitted to a mild stimulation protocol, which is not the routine approach in IVF clinics, where the aim is normally to achieve up to 15 oocytes [14]. Consequently, the generalizability to a conventional IVF protocol setting is however limited, due to the risk of high order multiple pregnancies. ...
Article
Full-text available
Purpose Failure to collect oocytes at the time of oocyte pick-up is an unfavorable outcome of in vitro fertilization (IVF) cycles. In these cases, prompt intrauterine insemination (IUI) could be an option (rescue IUI), but this possibility has been poorly studied. Methods Rescue IUI is routinely offered in our unit in women failing to retrieve oocytes, provided that they have at least one patent tube, normal male semen analysis, and the total number of developed follicles is ≤ 3. We therefore reviewed all oocyte retrievals performed from 2006 to 2022 in our unit to identify these cases. As a comparator, we referred to preplanned IUI performed during the same study period. The 95% confidence interval (95% CI) of proportions was calculated using a binomial distribution model. Results Rescue IUI was performed in 96 out of 3531 oocyte retrievals (2.7%; 95% CI 2.2–3.3%). Six live births were obtained, corresponding to 6.2% (95% CI 2.3–13.1). All pregnancies were singletons. Conclusions Rescue IUI in women failing to retrieve oocytes is a possible option that may be considered in selected cases. The efficacy is low, but the procedure is simple, and without significant risks. Generalizability to a conventional IVF protocol setting is however limited.
... La respuesta ovárica a la estimulación con gonadotropinas exógenas es un factor fundamental para el éxito de los procedimientos de fertilización asistida 1,2 . No obstante, la estandarización de una dosis segura y eficaz puede resultar difícil, dadas las diferencias en la respuesta individual de cada mujer a una misma dosis de gonadotropinas 2 . ...
... These outcomes are consistent with the results of earlier research [13]. The study of Sunkara et al. also indicated a close correlation between the number of oocytes retrieved and the live birth rate of women in IVF treatment, with the highest live birth rate observed when 15 oocytes were retrieved [14]. Moreover, this study demonstrated that DOR did not elevate the risk of miscarriage in young females receiving IVF treatment, which is in line with the findings of Haadsma et al. [15]. ...
Article
Full-text available
Objective This study aims to investigate the effect of diminished ovarian reserve (DOR) on the clinical outcomes and maternal and infant safety of in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) procedures in young women aged ≤ 35 years. Methods A retrospective cohort study was performed to analyze the clinical data of 4,203 infertile women aged ≤ 35 years who underwent fresh embryo transfer (ET) in IVF/ICSI cycles. The data were collected from their initial visits to Fujian Maternity and Child Health Hospital between January 2015 and January 2022. Based on their ovarian reserve, the participants were categorized into two groups: DOR group (n = 1,027) and non-DOR group (n = 3,176). A propensity score matching (PSM) method was employed to ensure a relatively balanced distribution of covariates. The primary outcome assessed in this study was the live birth rate, while the secondary observation indicators included rates of high-quality embryo development, blastocyst formation, clinical pregnancy, and miscarriage, along with perinatal complications, neonatal birth weight, and the incidence of low birth weight (LBW). Results The DOR group showed notably lowered rates of blastocyst formation (59.8% vs. 64.1%), embryo implantation (29.8% vs.33.3%), clinical pregnancy (47.9% vs. 53.6%), and live birth (40.6% vs. 45.7%) compared to the non-DOR group (all P < 0.05). However, no statistically significant differences were observed in the high-quality embryo rate, miscarriage rate, perinatal complications, neonatal birth weight, or LBW incidence in infants between both groups (all P > 0.05). Conclusion DOR has been found to reduce both clinical pregnancy and live birth rates in young females undergoing fresh ET in IVF/ICSI cycles. However, this reduction does not increase the risk of perinatal complications or LBW of infants through live birth cycles.
... In vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) are infertility treatments widely used, effective and with a low rate of complications [1]. One of the key factors affecting the success rate of the procedures is the ovarian stimulation with exogenous gonadotropins [2][3][4]. Available evidence demonstrates a positive linear correlation between the number of oocytes retrieved and the IVF success rates. A rapid increase in live birth rate (LBR) with the number of oocytes retrieved to approximately 16-20 oocytes, at which point it continued to increase but with diminishing returns, has been demonstrated [5]. ...
Article
Full-text available
Background Follitropin delta is a novel recombinant follicle stimulating hormone preparation uniquely expressed in a human fetal retinal cell line by recombinant DNA technology. To date, no systematic review was available about the safety and the efficacy of the follitropin delta. The objective of this study was systematically reviewing the available literature and to provide updated evidence regarding the efficacy-safety profile of follitropin delta when compared to other gonadotropin formulations for ovarian stimulation in in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) cycles. Methods An extensive search was performed to identify phase 1, phase 2 and phase 3 RCTs in humans focused on follitropin delta use for ovarian stimulation in IVF/ICSI cycles. The risk of bias and the overall quality of the evidence was analyzed. All data were extracted and analyzed using the intention-to-treat principle and expressed per woman randomized. Results A total of 7 RCTs (1 phase 1 RCT, 2 phase 2 RCTs and 4 phase 3 RCTs) were included in the qualitative analysis, whereas data of three phase 3 RCTs were meta-analyzed. All trials compared personalized recombinant follitropin delta treatment versus conventional recombinant follitropin alfa/beta administration in potentially normo-responder patients who receive ovarian stimulation in GnRH antagonist IVF/ICSI cycles. No difference between two regimens was detected for clinical pregnancy rate [odds ratio (OR) 1.06; 95% confidence intervals (CI): 0.90, 1.24; P = 0.49; I² = 26%], ongoing pregnancy rate (OR 1.15; 95%CI: 0.90, 1.46; P = 0.27; I² = 40%), and live birth rate (OR 1.18; 95%CI: 0.89, 1.55; P = 0.25; I² = 55%). No data were available regarding cumulative success rates. The rate of adoption of strategies to prevent ovarian hyperstimulation syndrome (OHSS) development (OR 0.45; 95%CI: 0.30, 0.66; P < 0.0001; I² = 0%), and the rate of both early OHSS (OR 0.62; 95%CI: 0.43, 0.88; P = 0.008; I² = 0%) and all forms of OHSS (OR 0.61; 95%CI: 0.44, 0.84; P = 0.003; I² = 0%) were significantly lower in the group of patients treated with personalized follitropin delta treatment compared to those treated with conventional follitropin alfa/beta administration. Conclusion Personalized follitropin delta treatment is associated with a lower risk of OHSS compared to conventional follitropin alfa/beta administration in potentially normo-responder patients who receive ovarian stimulation in GnRH antagonist IVF/ICSI cycles. The absence of cumulative data does not allow definitive conclusions to be drawn regarding the comparison of the effectiveness of the two treatments. Protocol study registration CRD42023470352 (available at http://www.crd.york.ac.uk/PROSPERO).
Preprint
Full-text available
Background Each controlled ovarian hyperstimulation(COH) protocol has its own unique mechanism and hormone pattern. The depot GnRHa protocol has a deeper down-regulation effect and favourable clinical pregnancy rates, the predictive model of the optimal follicle-stimulating hormone (FSH) starting dose in the early follicular phase depot GnRH agonist (EFDGa) protocol has not been reported. Our study was made to explore predictive indicators for determining the optimal FSH starting dose in patients undergoing ovarian stimulation with the EFDGa protocol in assisted reproductive technology (ART), and to develop and validate a nomogram prediction model for the starting dose of FSH. Methods This retrospective study included 2733 cycles who underwent fresh cycle transplantation at two large teaching hospitals in China from January to December 2022: center 1 (Reproductive Medicine Center of first affiliated Hospital of Zhengzhou University) provided the data for modelling (n = 938) and internal testing (n = 400), and center 2 (Reproductive Medicine Center of Jiangxi Maternal and Child Health Hospital) provided the data for external testing (n = 1109). Patient demographics, including age, anti-Mullerian hormone (AMH) levels, baseline endocrine profile, and body mass index (BMI), along with information on ovulation stimulation, were collected. Univariate and multivariate linear regression models were used to identify factors influencing the FSH starting dose. A nomogram for the ideal FSH starting dose was developed based on these factors and validated internally and externally. Bland and Altman plots and paired t-tests were conducted to verify the concordance and RMSE between groups. Results Univariate analysis revealed that patient age, BMI, baseline FSH, AMH, and antral follicle count (AFC) were indicators of FSH starting dose. The regression model for predicting FSH starting dose was determined as: Initial dose of FSH = 45.984 + 1.728 * AGE (years) + 5.131 * BMI (kg/m²) + 2.455 * bFSH (IU/ml) − 6.697 * AMH (ng/ml) – 3.339 * AFC. Bland and Altman analysis showed good agreement in the internal validation (bias: 0.629, SD of bias: 36.83, 95%LoA: -71.55–72.81 IU). Furthermore, validating the model on external cohort confirmed that nomogram prediction model is an accurate predictor of FSH starting dose ((bias: -1.428, SD of bias: 43.21, 95%LoA: -85.11–82.15 IU). Conclusions We established a model for effectively predicting the ideal FSH starting dose, with the nomogram model providing an intuitive representation of the data. The predictive model demonstrates practical utility, effectively initiating a proper ovarian response and preventing adverse ovarian reactions or the occurrence of ovarian hyperstimulation syndrome. As more IVF cycles are being generated in the future, this model will be valuable in clinicians using basic parameters to assess proper initial dose of FSH.
Article
Full-text available
Ovarian stimulation to achieve multiple follicle development has been an integral part of IVF treatment. In the context of improved laboratory performance, the need for a large number of oocytes as an integral part of a successful IVF programme may be questioned. The aim of the current debate is to summarize the studies performed during the last decade to develop the concept of mild stimulation aiming to obtain fewer than eight oocytes. Here we examine the balance between IVF success and patient discomfort, and complications and cost, and how these might improve by simpler ovarian stimulation protocols aimed at retrieving fewer oocytes. We intend to analyse why progress has been rather slow and why there is much resistance to mild stimulation. Finally, presumed useful directions for future research will be discussed.
Article
Abstract Introduction: The success of IVF/ICSI cycles depends on satisfactory ovarian response to stimulation. The number of oocytes collected per stimulation cycle has been used among other parameters to assess adequate response in controlled ovarian stimulation with gonadotrophins. However, the optimal number of retrieved oocytes that maximises cycle outcome is not known. Material and Methods: Cycle outcomes were assessed in relation to the number of oocytes collected after controlled ovarian stimulation. Logistic regressions were used to assess the effect of women's age, BMI, early follicular FSH, days of FSH stimulation, number of stimulated follicles and oocytes collected (as dependant variables), on the clinical pregnancy rates and on the chances of having embryos to freeze (as independent variables). Results: A total of 4,701 consecutive fresh IVF/ICSI cycles carried out between September 2004 and October 2009 were included. The mean (SD) age of women was 36 (4.48) years, the mean (SD) daily dose of FSH for stimulation was 277 iu (101.1), while the mean (SD) number of stimulated follicles and eggs collected was 11.1 (7.0) and 10.6 (6.9), respectively. The mean (SD) number of embryos replaced was 1.8 (0.51) and a total of 1403 (30%) women achieved a clinical pregnancy. There was a significant association between the number of eggs collected and the chances of proceeding to embryo transfer (ET) [1-3 eggs: 71.3% reached ET, 4-6 eggs: 91.3%, 7-10 eggs: 95.3%, 11-15 eggs: 97.2% and >15 eggs: 96.9%. P < 0.001). No significant association was noted between the fertilisation rates and number of eggs collected (1-3 eggs: 56%, 4-6 eggs: 54%, 7-10 eggs: 55%, 11-15 eggs: 57% and >15 eggs: 54%. P = 0.36). The proportion of women having blastocyst transfer increased as the number of eggs collected increased. (1-3 eggs: 0.5%, 4-6 eggs: 3.4%, 7-10 eggs: 13.8%, 11-15 eggs: 30.2% and >15 eggs: 41.6%. P < 0.001). No further increase in the proportion of blastocyst transfers was noted beyond 15 eggs (eggs 16-20: 40%, eggs >20 %, 43.6. P = 0.28). Clinical pregnancy rates increased as the number of eggs collected increased (1-3 eggs: 13.3%, 4-6 eggs: 24.6%, 7-10 eggs: 33.4%, 11-15 eggs: 38.2% and >15 eggs: 41.9%. P < 0.001). However, after adjusting for age and other variables through logistic regressions, the increase in the clinical pregnancy rates was only noted with an increase up to six eggs (P < 0.001 OR: 0.49 95%CI: 0.34 to 0.71), with no significant increase in clinical pregnancy in women who had more than six eggs collected. The proportion of women having at least one embryo frozen increased as the number of eggs collected increased (1-3 eggs: 0.9% had freezing, 4-6 eggs: 7.2%, 7-10 eggs: 22.9%, 11-15 eggs: 38.5% and 16-20 eggs: 53.6%. P < 0.001). Logistic regression analysis, showed that after adjusting for variables, the chances of having surplus embryo to freeze, increased as the number of eggs increased up to 18 eggs (P = 0.02, OR: 0.62, 95%CI: 0.42 to 0.92), with no significant improvement in women who had more than 18 eggs collected. Conclusions: The proportion of women having blastocyst transfer and the clinical pregnancy rates, increased with the number of eggs collected. After adjusting for variables, the clinical pregnancies increased proportionately with the number of eggs collected, up to six eggs, but a plateau was noted beyond that. A similar increase was noted in the proportion of women having surplus embryos to freeze and this effect ceased beyond 18 eggs. This information could be useful in planning stimulation protocols and counselling women undergoing IVF/ICSI treatment.
Article
Objetives: To evaluate the pregnancy rate of the cycles IVF-ICSI according to the number of retrieved oocytes and establish a correlation between this variable and others (age, mature oocytes, the average of embryos obtained, fecundation rate etc). Materials and methods: Retrospective study of 299 retrieved cycles of IVF-ICSI between January and December 2006. Stimulation protocols: long with agonists and short with antagonists of GNRH and stimulation with FSHr alone or in combination with HMG or LHr. The sample was divided into three groups according to the number of retrieved oocytes: group 1 (0-6), group 2 (7-16) and group 3 (>16). Results: With regard to the total of the sample, the average of oocytes, that each cycle had, was 9,44 ± 5,7. The total pregnancy rate/ embryo transfer was of 33,7%. The pregnancy rate was 21%, 40% and 38,5% for each one of the study groups, differences that were statistically significant (p< 0,05). We find significant differences in the three groups of study: patients' ave rage age and ave rage of embryos. The biggest fecundation rate was obtained in group 2 (76, 35%). Comparing the thre e groups, the differences were not significant. We find that the optimum range of oocytes with the best results was group 2 (6 - 16 oocytes) with an oocytes ave rage of 10, 5. Group 2 was related to a lower number of embryos, and to a lower fecundation and pregnancy rate. Group 3 was related to a higher cancellation rate of embryo transfer due to the risk of OHS (ovarian hy perstimulation syndrome), without a higher pregnancy rate. Conclusions: Although personal considerations need to be done, we consider that the trend should be that of using protocols of moderate treatments that will get a reasonable number of oocytes. In our case the best results were obtained in group 2 (7-16), with an average of 10, 5 oocytes.
Article
IntroductionBackground Using the Bootstrap to Explore Model StabilityExample 1: Glioma DataExample 2: Educational Body-Fat DataExample 3: Breast Cancer DiagnosisModel Stability for FunctionsExample 4: GBSG Breast Cancer DataDiscussion
Article
To determine an optimal serum E(2) level on the day of hCG administration in controlled ovarian hyperstimulation (COH) during IVF-ET without compromising pregnancy outcome. Retrospective study. Large urban medical center. Data of 455 cycles of fresh IVF-ET with COH. Serum E(2) levels on the day of hCG administration were categorized into five groups: group A (<1000 pg/mL), group B (1000-2000 pg/mL), group C (2000-3000 pg/mL), group D (3000-4000 pg/mL), and group E (>4000 pg/mL). Serum E(2) levels, number of oocytes retrieved, pregnancy outcomes. Of 455 cycles, 148 (32.5%) cycles resulted in clinical pregnancy. The implantation rate was 12.2%, and the delivery rate was 18.7%. The number of oocytes obtained increased with increasing serum E(2) levels. The pregnancy rate gradually increased from group A to D as E(2) levels increased but decreased in group E. In women <38 years, the IVF-ET outcomes were similar to those of total patients. However, in women >/=38 years old, pregnancy and delivery rates were higher in group C than in other groups. These results show that serum E(2) levels have a concentration-dependent effect on the pregnancy outcome, suggesting an optimal range of E(2) level for achieving a successful pregnancy. This optimal range of serum E(2) level in women is age dependent: 3000-4000 pg/mL for women <38 years and 2000-3000 pg/mL for women >/=38 years.
Article
To clarify the differences in clinical characteristics between early and late ovarian hyperstimulation syndrome (OHSS). Retrospective study. Tertiary university hospital. Ninety-four patients/cycles hospitalized for moderate-to-severe OHSS after controlled ovarian hyperstimulation (COH) for IVF/intracytoplasmic sperm injection (ICSI); early type (n = 69) and late type (n = 25). None. The COH and pregnancy outcomes, preclinical and clinical miscarriage rate, and hospital courses. Serum E(2) levels (4,955.5 +/- 3,268.5 pg/mL vs. 2,340.8 +/- 960.6 pg/mL) and the number of follicles > or =11 mm on day of hCG administration (15.9 +/- 6.0 vs. 13.0 +/- 4.0), and the number of oocytes retrieved (21.9 +/- 9.7 vs. 13.2 +/- 5.9) were significantly higher in the early OHSS group compared with the late OHSS group. Clinical pregnancy rate (PR) was significantly higher in the late OHSS group (23.6% [13/55] vs. 92.0% [23/25]). There were no significant differences in multiple PR and disease severity between the two groups. Early OHSS is associated with excessive ovarian response to gonadotropin stimulation, whereas late OHSS is closely associated with conception cycle. Our findings do not support that late OHSS is more severe and closely associated with multiple pregnancies compared with early OHSS.
Article
Since in vitro fertilization/embryo transfer is used as a common assisted reproductive technique there have been attempts to increase its success rate. One way is to obtain more good quality mature ovules to fertilize them, and two to three good quality embryos to transfer. To determine if the number of retrieved oocytes is related with the pregnancy rate in IVF-ET. Reproductive and descriptive study; 172 patients in the IVF program were included. Whole patients had ovary stimulation with FSHr and antagonist multidose protocol. Five study groups were considered depending on the oocyte number retrieved. Data were analized and correlated with fertilization and pregnancy rate. There were no statistical differences among age, body mass index, percentage of mature oocyte, fertilization rate, embryo cell stage or basal levels of LH and Estradiol. Group three showed the highest pregnancy rate (64.29%) nevertheless group five had major number of embryo transferred (2.97 +/- 0.54 vs 3.17 +/- 0.45, p = 0.21). According to FSH doses given, group one had statistical difference related to group three, with higher dose (54.1 vs 62.1). According to previous studies, related to the number of oocyte retrieved, the possibility of pregnancy is higher with more than 13 oocytes retrieved (OR: 0.9 IC 95%: 0.4 -1.7). Pregnancy rate is higher when ten to fifteen oocytes were retrieved.
Article
Ovarian hyperstimulation syndrome (OHSS) is a rare but potentially fatal complication of IVF treatment. The risk of OHSS increases with increasing numbers of follicles aspirated and oocytes retrieved, but there is little evidence to support whether threshold values of either can be used to correctly predict OHSS. Since the most severe forms of OHSS are usually associated with pregnancy, cryopreservation of all embryos may prevent this. The authors attempted to find thresholds of follicle and oocyte numbers that would optimally predict OHSS, through a retrospective analysis of 2253 consecutive cycles of IVF/intracytoplasmic sperm injection treatment reaching oocyte retrieval, between 1 January 2003 and 31 March 2006. Receiver operator characteristic (ROC) curves were calculated for both parameters, to determine threshold values that might predict OHSS in women with > or =20 oocytes. For the prediction of early onset OHSS, ROC curves showed that an optimal balance between sensitivity and specificity was achieved using thresholds of 24 oocytes (79%, 60%) and 29 follicles (82%, 65%) respectively. Using these thresholds, cryopreservation of all embryos may be offered as an alternative to cancellation of a treatment cycle due to excessive ovarian response, thus minimizing the number of unnecessary interventions while still correctly predicting most cases of early onset OHSS.
Article
This study was designed to identify clinical predictors for early and late ovarian hyperstimulation syndrome (OHSS). A retrospective analysis of all 592 in-vitro fertilization (IVF) cycles from the programme's inception in 1988 up to March 1993 was performed. Six patients (1.0% of cycles) had moderate or severe OHSS presenting 3-7 days post-human chorionic gonadotrophin (HCG), and four patients (0.7% of cycles) had severe OHSS presenting 12-17 days post-HCG. No patient with early OHSS went on to develop late OHSS, and no patient with late OHSS had demonstrated early OHSS. Stepwise logistic regression showed that early OHSS was predicted by the number of oocytes retrieved (range 18-46) (P = 0.0001) and the oestradiol concentration on the day HCG was given (range 12,122-24,454 pmol/l) (P = 0.0003). Late OHSS was predicted by the number of gestational sacs (range 2-3) on ultrasound 4 weeks after embryo transfer (P = 0.0001) but not by the number of oocytes or oestradiol. Early OHSS was an acute effect of the HCG administered prior to egg retrieval in women with high oestradiol and larger numbers of follicles (range 22-51). Late OHSS was induced by the rising serum concentration of HCG produced by the early pregnancy, and in this series of cases it was associated only with multiple gestation.